MAPT and supranuclear palsy, progressive, 1: Cumulatively, these results are consistent with a strong association of pathological tau and SUMO1 in affected neurons in PSP but SUMO1 weak modification of tau is seen in astrocytic pathology and glial SUMO1 may be linked to other aggregated proteins in non-neuronal cells.